The World Intellectual Property Organization (WIPO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Interpat have launched a new partnership that underlines a shared commitment to intellectual property supporting health innovation.
The new collaboration is designed to support startups and small and medium-sized enterprises (SMEs) from the health technology, MedTech and biotechnology sectors in making strategic use of intellectual property (IP) to promote innovation.
The Memorandum of Understanding (MoU), signed at WIPO headquarters on June 29, 2026, provides a framework for collaboration that combines WIPO’s expertise in intellectual property management delivered through its Intellectual Property Management Clinics (IPMCs), with IFPMA’s global network of pharmaceutical industry associations and Interpat’s community of senior intellectual property and patent professionals.